Synthesis and Antitumor Efficacy of a β-Glucuronidase-Responsive Albumin-Binding Prodrug of Doxorubicin

Synthesis and Antitumor Efficacy of a β-Glucuronidase-Responsive Albumin-Binding Prodrug of Doxorubicin A β-glucuronidase-responsive albumin-binding prodrug for potential selective kinase inhibitor-based cancer chemotherapy A self-immolative dendritic glucuronide prodrug of doxorubicin Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog Prodrugs of Anthracyclines for Use in Antibody-Directed Enzyme Prodrug Therapy Probing the Cysteine-34 Position of Endogenous Serum Albumin with Thiol-Binding Doxorubicin Derivatives. Improved Efficacy of an Acid-Sensitive Doxorubicin Derivative with Specific Albumin-Binding Properties Compared to That of the Parent Compound Development of dual-acting prodrugs for circumventing multidrug resistance Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) β-glucuronide and β-galactoside for application in selective prodrug chemotherapy Benzyl Ether-Linked Glucuronide Derivative of 10-Hydroxycamptothecin Designed for Selective Camptothecin-Based Anticancer Therapy